Research from a University of Saskatchewan (USask) College of Medicine team will help develop medications that can inhibit the nerve cell damage that occurs due to diseases such as multiple sclerosis (MS). The research team has modeled the mechanisms by which a specific cell protein, A1, causes damage to nerve cells, expanding on previous USask […]